NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 348 filers reported holding NEKTAR THERAPEUTICS in Q4 2018. The put-call ratio across all filers is 0.59 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $90 | -69.5% | 128,708 | -1.7% | 0.00% | -75.0% |
| Q4 2022 | $295 | -99.9% | 130,878 | +0.9% | 0.00% | -33.3% |
| Q3 2022 | $415,000 | -22.4% | 129,745 | -7.9% | 0.01% | -14.3% |
| Q2 2022 | $535,000 | -22.6% | 140,915 | +9.8% | 0.01% | 0.0% |
| Q1 2022 | $691,000 | -60.8% | 128,380 | -1.8% | 0.01% | -58.8% |
| Q4 2021 | $1,765,000 | +242.1% | 130,670 | +354.2% | 0.02% | +240.0% |
| Q3 2021 | $516,000 | +7.1% | 28,772 | +2.2% | 0.01% | 0.0% |
| Q2 2021 | $482,000 | -15.4% | 28,145 | -1.2% | 0.01% | -16.7% |
| Q1 2021 | $570,000 | +15.4% | 28,501 | -2.1% | 0.01% | 0.0% |
| Q4 2020 | $494,000 | -2.4% | 29,103 | -4.7% | 0.01% | 0.0% |
| Q3 2020 | $506,000 | -31.0% | 30,523 | -3.6% | 0.01% | -33.3% |
| Q2 2020 | $733,000 | +35.7% | 31,678 | +4.7% | 0.01% | 0.0% |
| Q1 2020 | $540,000 | -13.5% | 30,270 | +4.6% | 0.01% | +12.5% |
| Q4 2019 | $624,000 | +10.1% | 28,926 | -7.2% | 0.01% | 0.0% |
| Q3 2019 | $567,000 | -61.5% | 31,178 | -24.8% | 0.01% | -68.0% |
| Q2 2019 | $1,473,000 | -12.4% | 41,436 | -17.3% | 0.02% | -16.7% |
| Q1 2019 | $1,682,000 | +5.9% | 50,112 | +3.6% | 0.03% | -3.2% |
| Q4 2018 | $1,589,000 | -42.9% | 48,377 | +6.0% | 0.03% | -34.0% |
| Q3 2018 | $2,781,000 | +32.7% | 45,646 | +6.3% | 0.05% | +27.0% |
| Q2 2018 | $2,095,000 | +189.4% | 42,960 | +529.9% | 0.04% | +146.7% |
| Q1 2018 | $724,000 | -61.3% | 6,820 | -78.3% | 0.02% | -66.7% |
| Q4 2017 | $1,873,000 | +152.1% | 31,375 | +1.3% | 0.04% | +18.4% |
| Q3 2017 | $743,000 | +24.2% | 30,985 | +1.2% | 0.04% | -7.3% |
| Q2 2017 | $598,000 | +49.5% | 30,625 | +79.6% | 0.04% | +41.4% |
| Q1 2017 | $400,000 | +97.0% | 17,050 | +2.8% | 0.03% | +52.6% |
| Q4 2016 | $203,000 | – | 16,590 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 3,500,000 | $60,060,000 | 2.02% |
| ACT CAPITAL MANAGEMENT, LLC | 161,500 | $2,772,000 | 1.42% |
| Rhenman & Partners Asset Management AB | 950,000 | $16,302,000 | 1.11% |
| MAVERICK CAPITAL LTD | 5,761,073 | $98,860,000 | 0.93% |
| Birchview Capital, LP | 72,000 | $1,236,000 | 0.74% |
| Bellevue Group AG | 4,101,404 | $70,380,000 | 0.69% |
| CM Management, LLC | 50,000 | $858,000 | 0.62% |
| Duquesne Family Office | 1,000,000 | $17,160,000 | 0.42% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 373,368 | $6,407,000 | 0.33% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 67,000 | $1,149,000 | 0.30% |